104 related articles for article (PubMed ID: 8113987)
1. Morphine-induced excitation of pyramidal neurons is inhibited by cholecystokinin in the CA1 region of the rat hippocampal slice.
Miller KK; Lupica CR
J Pharmacol Exp Ther; 1994 Feb; 268(2):753-61. PubMed ID: 8113987
[TBL] [Abstract][Full Text] [Related]
2. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
Gronier B; Debonnel G
Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of opioid effects in the rat hippocampal slice.
Valentino RJ; Dingledine R
J Pharmacol Exp Ther; 1982 Nov; 223(2):502-9. PubMed ID: 6752374
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin inhibits evoked inhibitory postsynaptic currents in the rat nucleus accumbens indirectly through gamma-aminobutyric acid and gamma-aminobutyric acid type B receptors.
Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
J Neurosci Res; 2005 Feb; 79(3):412-20. PubMed ID: 15605383
[TBL] [Abstract][Full Text] [Related]
5. Effects of the Aconitum alkaloid mesaconitine in rat hippocampal slices and the involvement of alpha- and beta-adrenoceptors.
Ameri A
Br J Pharmacol; 1998 Jan; 123(2):243-50. PubMed ID: 9489612
[TBL] [Abstract][Full Text] [Related]
6. Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices.
Ferraro L; Beani L; Trist D; Reggiani A; Bianchi C
J Neurochem; 1999 Nov; 73(5):1973-81. PubMed ID: 10537055
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice.
Su MT; Lin WB; Lue WM; Cheng CY; Tao PL
Br J Pharmacol; 1998 Feb; 123(4):625-30. PubMed ID: 9517380
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
Wan S; Coleman FH; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G484-92. PubMed ID: 17569742
[TBL] [Abstract][Full Text] [Related]
9. Morphine dependence increases the response to a brief pentylenetetrazol administration in rat hippocampal CA1 in vitro.
Jafarzadeh Z; Fathollahi Y; Semnanian S; Omrani A; Salmanzadeh F; Salmani ME
Epilepsia; 2009 Apr; 50(4):789-800. PubMed ID: 19183220
[TBL] [Abstract][Full Text] [Related]
10. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons.
Miller KK; Hoffer A; Svoboda KR; Lupica CR
J Neurosci; 1997 Jul; 17(13):4994-5003. PubMed ID: 9185537
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effect of CCK-8S on GABA-induced depolarization from rat dorsal root ganglion.
Ma KT; Si JQ; Zhang ZQ; Zhao L; Fan P; Jin JL; Li XZ; Zhu L
Brain Res; 2006 Nov; 1121(1):66-75. PubMed ID: 17055464
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide FF inhibition of morphine effects in the rat hippocampus.
Miller KK; Lupica CR
Brain Res; 1997 Mar; 750(1-2):81-6. PubMed ID: 9098532
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro.
Voigt M; Wang RY; Westfall TC
J Pharmacol Exp Ther; 1986 Apr; 237(1):147-53. PubMed ID: 3958963
[TBL] [Abstract][Full Text] [Related]
15. Effect of the selective 5-HT1A receptor antagonist WAY 100635 on the inhibition of e.p.s.ps produced by 5-HT in the CA1 region of rat hippocampal slices.
Pugliese AM; Passani MB; Corradetti R
Br J Pharmacol; 1998 May; 124(1):93-100. PubMed ID: 9630348
[TBL] [Abstract][Full Text] [Related]
16. The contrasting effects of dendrotoxins and other potassium channel blockers in the CA1 and dentate gyrus regions of rat hippocampal slices.
Southan AP; Owen DG
Br J Pharmacol; 1997 Sep; 122(2):335-43. PubMed ID: 9313944
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological changes in rat hippocampal pyramidal neurons produced by cholecystokinin octapeptide.
Shinohara S; Kawasaki K
Neuroscience; 1997 Jun; 78(4):1005-16. PubMed ID: 9174069
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
Corradetti R; Le Poul E; Laaris N; Hamon M; Lanfumey L
J Pharmacol Exp Ther; 1996 Aug; 278(2):679-88. PubMed ID: 8768719
[TBL] [Abstract][Full Text] [Related]
19. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.
Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E
Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657
[TBL] [Abstract][Full Text] [Related]
20. Action of methylmercury on GABA(A) receptor-mediated inhibitory synaptic transmission is primarily responsible for its early stimulatory effects on hippocampal CA1 excitatory synaptic transmission.
Yuan Y; Atchison WD
J Pharmacol Exp Ther; 1997 Jul; 282(1):64-73. PubMed ID: 9223540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
